Brain Lipid Binding Protein in Axon-Schwann Cell Interactions and Peripheral Nerve Tumorigenesis

REFERENCES

• Adlkofer, K., and C. Lai. 2000. Role of neuregulins in glial cell development. Glia 29: 104–111.
   PubMedGoogle Scholar
• Anton, E. S., M. A. Marchionni, K.-F. Lee, and P. Rakic. 1997. Role of GGF/neuregulin signaling interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 124: 3501–3510.
   PubMed Web of Science ®Google Scholar
• Arroyo, E. J., J. R. Bermingham, M. G. Rosenfeld, and S. S. Scherer. 1998. Promyelinating Schwann cells express Tst-1/SCIP/Oct-6. J. Neurosci. 18: 7891–7902.
   PubMedGoogle Scholar
• Balendiran, G. K., F. Schnutgen, G. Scapin, T. Borchers, N. Xhong, K. Lim, R. Godbout, F. Spener, and J. C. Sacchettini. 2000. Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J. Biol. Chem. 275: 27045–27054.
   PubMed Web of Science ®Google Scholar
• Basu, T. N., D. H. Gutmann, J. A. Fletcher, T. W. Glover, F. S. Collins, and J. Downward. 1992. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 663–664.
   PubMedGoogle Scholar
• Bennett, E., K. L. Stenvers, P. K. Lund, and B. Popko. 1994. Cloning and characterization of a cDNA encoding a novel fatty acid binding protein from rat brain. J. Neurochem. 63: 1616–1624.
   PubMedGoogle Scholar
• Bisgrove, D. A., E. A. Monckton, M. Packer, and R. Godbout. 2000. Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines. J. Biol. Chem. 275: 30668–30676.
   PubMedGoogle Scholar
• Bollag, G., and F. McCormick. 1991. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351: 576–579.
   PubMed Web of Science ®Google Scholar
• Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 115: 453–466.
   PubMed Web of Science ®Google Scholar
• Brannan, C. I., A. S. Perkins, K. S. Vogel, N. Ratner, M. L. Nordlund, S. W. Reid, A. M. Buchberg, N. A. Jenkins, L. F. Parada, and N. G. Copleland. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8: 1019–1029.
   PubMed Web of Science ®Google Scholar
• Celis, J. E., M. Ostergaard, B. Basse, A. Celis, J. B. Lauredsin, G. P. Ratz, I. Anderson, B. Hein, H. Wolf, T. Orntoft, and H. H. Rasmussen. 1996. Loss of adipocyte-type fatty acid binding protein and other biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res. 56: 4782–4790.
   PubMed Web of Science ®Google Scholar
• Chandross, K. J., R. I. Cohen, P. Paras, M. Gravel, P. E. Braun, and L. D. Hudson. 1999. Identification and characterization of early glial progenitors using a transgenic selection strategy. J. Neurosci. 19: 759–774.
   PubMedGoogle Scholar
• Cichowski, K., and T. Jacks. 2001. NF1 tumor suppressor function: narrowing the GAP. Cell 104: 593–604.
   PubMed Web of Science ®Google Scholar
• Cichowski, K., T. S. Shih, E. Schmitt, S. Santiago, K. Reilly, M. E. McLaughlin, R. T. Bronson, and T. Jacks. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286: 2172–2176.
   PubMed Web of Science ®Google Scholar
• Custer, R. P., and S. Sorof. 1984. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasia in adult hepatocytes. Proc. Natl. Acad. Sci. USA 81: 7638–7642.
   Google Scholar
• Das, R., R. Hammamieh, R. Neill, M. Melhem, and M. Jett. 2001. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin. Cancer Res. 7: 1706–1715.
   PubMed Web of Science ®Google Scholar
• DeClue, J. E., S. Heffelfinger, G. Benvenuto, B. Ling, S. Li, W. Rui, W. C. Vass, D. Viskochil, and N. Ratner. 2000. Epidermal growth factor receptor expression in neurofibromatosis type-1 related tumors and NF1 animal models. J. Clin. Investig. 105: 1–10.
   Google Scholar
• DeClue, J. E., A. G. Papageorge, J. A. Fletcher, S. R. Diehl, N. Ratner, W. C. Vass, and D. R. Lowy. 1992. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69: 265–273.
   PubMedGoogle Scholar
• Dong, Z., A. Sinanan, D. Parkinson, E. Parmantier, R. Mirsky, and K. R. Jessen. 1999. Schwann cell development in embryonic mouse nerves. J. Neurosci. Res. 56: 334–348.
   PubMedGoogle Scholar
• Feng, L., M. E. Hatten, and N. Heintz. 1994. Brain lipid binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron 12: 895–908.
   PubMed Web of Science ®Google Scholar
• Feng, L., and N. Heintz. 1995. Differentiating neurons activate transcription of the brain lipid binding protein gene in radial glia through a novel regulatory element. Development 121: 1719–1730.
   PubMedGoogle Scholar
• Godbout, R., D. A. Bisgrove, D. Shkolny, and R. S. Day. 1998. Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 16: 1955–1962.
   PubMedGoogle Scholar
• Golubic, M., J. A. Harwalkar, S. S. Bryant, V. Sundaram, R. Jove, and J. H. Lee. 1998. Differential regulation of neurofibromin and p120 GTPase-activating protein by nutritionally relevant fatty acids. Nutr. Cancer 30: 97–107.
   PubMed Web of Science ®Google Scholar
• Guha, A., N. Lau, I. Huvar, D. Gutman, J. Provias, T. Pawson, and G. Boss. 1996. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12: 507–513.
   PubMed Web of Science ®Google Scholar
• Gygi, S. P., Y. Rochon, B. R. Franza, and R. Aebersold. 1999. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19: 1720–1730.
   PubMed Web of Science ®Google Scholar
• Han, J. W., F. McCormick, and I. G. Macara. 1991. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids. Science 252: 576–579.
   PubMed Web of Science ®Google Scholar
• Ideker, T., V. Thorsson, J. A. Ranish, R. Christmas, J. Buhler, J. K. Eng, R. Bumgarner, D. R. Goodlett, R. Aebersold, and L. Hood. 2001. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929–934.
   PubMed Web of Science ®Google Scholar
• Jacks, T., T. S. Shih, E. M. Schmitt, R. T. Bronson, A. Bernards, and R. A. Weinberg. 1994. Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nat. Genet. 7: 353–361.
   PubMed Web of Science ®Google Scholar
• Josephson, R., T. Muller, J. Pickel, S. Okabe, K. Reynolds, P. A. Turner, A. Zimmer, and R. D. McKay. 1998. POU transcription factors control expression of CNS stem cell-specific genes. Development 125: 3087–3100.
   PubMed Web of Science ®Google Scholar
• Kim, H. A., B. Ling, and N. Ratner. 1997. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol. Cell. Biol. 17: 862–872.
   PubMedGoogle Scholar
• Kim, H. A., T. Rosenbaum, M. A. Marchionni, N. Ratner, and J. E. DeClue. 1995. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene 11: 325–335.
   PubMedGoogle Scholar
• Kluwe, L., R. Friedrich, and V. Mautner. 1999. Loss of NF1 allele in Schwann cells but not fibroblasts derived from an NF1-associated neurofibroma. Genes Chromosomes Cancer 24: 283–285.
   PubMed Web of Science ®Google Scholar
• Kohl, N. E., S. D. Mosser, J. deSolms, E. A. Giuliani, D. L. Pompliano, S. L. Graham, R. L. Smith, E. M. Scolnick, A. Oliff, and J. B. Gibbs. 1995. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat. Med. 1: 792–797.
   PubMed Web of Science ®Google Scholar
• Kurtz, A., A. Zimmer, F. Schnutgen, G. Bruning, F. Spener, and T. Muller. 1994. The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development 120: 2637–2649.
   PubMed Web of Science ®Google Scholar
• Legius, E., D. A. Marchuk, F. S. Collins, and T. W. Glover. 1993. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat. Genet. 3: 122–126.
   PubMed Web of Science ®Google Scholar
• Li, H., S. Velasco-Miguel, W. C. Vass, L. F. Parada, and J. E. DeClue. 2002. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model. Cancer Res. 62: 4507–4513.
   PubMed Web of Science ®Google Scholar
• Nieke, J., and M. Schachner. 1985. Expression of the neural cell adhesion molecules L1 and N-CAM and their common carbohydrate epitope L2/HNK-1 during development and after transection of the mouse sciatic nerve. Differentiation 30: 141–151.
   PubMed Web of Science ®Google Scholar
• Parysek, L. M., and R. D. Goldman. 1987. Characterization of intermediate filaments in PC12 cells. J. Neurosci. 7: 781–791.
   PubMedGoogle Scholar
• Quilliam, L. A., K. Kato, K. M. Rabun, M. M. Hisaka, S. Y. Huff, S. Campbell-Burk, and C. J. Der. 1994. Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interactions with guanine nucleotide exchange factors. Mol. Cell. Biol. 14: 1113–1121.
   PubMedGoogle Scholar
• Rajeevan, M. S., D. G. Ranamukhaarachchi, S. D. Vernon, and E. R. Unger. 2001. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25: 443–451.
   PubMed Web of Science ®Google Scholar
• Ramdas, L., K. R. Coombes, K. Baggerly, L. Abruzzo, W. E. Highsmith, T. Krogman, S. R. Hamilton, and W. Zhang. 2001. Sources of nonlinearity in cDNA microarray expression measurements. Genome Biol. 2: 1–7.
   Google Scholar
• Rasmussen, H. H., T. F. Orntoft, H. Wolf, and J. E. Celis. 1996. Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J. Urol. 155: 2113–2119.
   PubMed Web of Science ®Google Scholar
• Richieri, G. V., R. T. Ogata, A. W. Zimmerman, J. H. Veerkamp, and A. M. Kleinfeld. 2000. Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry 39: 7197–7204.
   PubMed Web of Science ®Google Scholar
• Rickman, D. S., M. P. Bobek, D. E. Misek, R. Kuick, M. Blaivas, D. M. Kurnit, J. Taylor, and S. Hanash. 2001. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61: 6885–6891.
   PubMed Web of Science ®Google Scholar
• Rizvi, T. A., Y. Huang, A. Sidani, R. Atit, D. A. Largaespada, R. E. Boissy, and N. Ratner. 2002. A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. J. Neurosci. 22: 9831–9840.
   PubMedGoogle Scholar
• Sebti, S., and A. D. Hamilton. 1997. Inhibitors of prenyl transferases. Curr. Opin. Oncol. 9: 557–561.
   PubMedGoogle Scholar
• Sermon, B. A., J. F. Eccleston, R. H. Skinner, and P. N. Lowe. 1996. Mechanism of inhibition by arachidonic acid of the catalytic activity of Ras GTPase-activating proteins. J. Biol. Chem. 271: 1566–1572.
   PubMed Web of Science ®Google Scholar
• Serra, E., T. Rosenbaum, U. Winner, R. Aledo, E. Ars, X. Estivill, H.-G. Lenard, and C. Lazaro. 2000. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell populations. Hum. Mol. Genet. 9: 3055–3064.
   PubMed Web of Science ®Google Scholar
• Sherman, L. S., R. Atit, T. Rosenbaum, A. D. Cox, and N. Ratner. 2000. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. J. Biol. Chem. 275: 30740–30745.
   PubMed Web of Science ®Google Scholar
• Shimizu, F., T. K. Watanabe, H. Shinomiya, Y. Nakamura, and T. Fujiwara. 1997. Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP). Biochim. Biophys. Acta 1354: 24–28.
   PubMedGoogle Scholar
• Tamanoi, F. 1993. Inhibitors of Ras: farnesyltransferases. Trends Biochem. Sci. 18: 349–353.
   PubMed Web of Science ®Google Scholar
• Velu, T. J., L. Beguinot, W. C. Vass, M. C. Willingham, G. T. Merlino, I. Pastan, and D. R. Lowy. 1987. Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238: 1408–1410.
   PubMed Web of Science ®Google Scholar
• Vogel, K. S., L. J. Klesse, S. Velasco-Miguel, K. Meyers, E. J. Rushing, and L. F. Parada. 1999. Mouse tumor model for neurofibromatosis type 1. Science 286: 2176–2179.
   PubMed Web of Science ®Google Scholar
• Webster, H. D. 1993. Development of peripheral nerve fibers, p. 243–266. In P. J. Dyck, P. K. Thomas, P. A. Low, and J. F. Poduslo (ed.), Peripheral neuropathy. The W. B. Saunders Co., Philadelphia, Pa.
   Google Scholar
• White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. H. Wigler. 1995. Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533–541.
   PubMed Web of Science ®Google Scholar
• Xu, L. Z., R. Sanchez, A. Sali, and N. Heintz. 1996. Ligand specificity of brain lipid-binding protein. J. Biol. Chem. 271: 24711–24719.
   PubMed Web of Science ®Google Scholar
• Yan, N., C. Ricca, J. Fletcher, T. Glover, B. R. Seizinger, and V. Manne. 1995. Farnesyltransferase inhibitors block the neurofibromatosis type 1 (NF1) malignant phenotype. Cancer Res. 55: 3569–3575.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and M. X. Sliwkowski. 2001. Untangling the ErbB signalling network. Nat. Rev. 2: 127–137.
   Google Scholar
• Zhu, Y., P. Ghosh, P. Charnay, D. K. Burns, and L. F. Parada. 2002. NF1 associated neurofibromas initiate in Schwann cells and require a haploinsufficient environment. Science 296: 920–922.
   PubMed Web of Science ®Google Scholar